Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
29.2M
-
Shares change
-
+427K
-
Total reported value, excl. options
-
$73.6M
-
Value change
-
+$1.18M
-
Put/Call ratio
-
3.07
-
Number of buys
-
31
-
Number of sells
-
-27
-
Price
-
$2.52
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q4 2020
86 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q4 2020.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.2M shares
of 52.3M outstanding shares and own 55.85% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.62M shares), BlackRock Inc. (3.76M shares), RENAISSANCE TECHNOLOGIES LLC (3.56M shares), Roumell Asset Management, LLC (2.77M shares), Evermore Global Advisors, LLC (2.61M shares), VANGUARD GROUP INC (2.4M shares), DIMENSIONAL FUND ADVISORS LP (1.7M shares), ARIEL INVESTMENTS, LLC (871K shares), STATE STREET CORP (848K shares), and GEODE CAPITAL MANAGEMENT, LLC (599K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.